Supporting this, both constitutive deletion of the GATA2+9.5 enhancer (strongly active in developing embryonic ECs)72 and endothelial‐specific deletions of Gata2 result in lethality at E13–16.5 with vascular abnormalities including hemorrhage, edema, and anemia. This evidence concerns the gene GATA2 and anemia (phenotype).